You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

CLINICAL TRIALS PROFILE FOR HISTAMINE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for histamine

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00003991 ↗ Interleukin-2 Plus Histamine Dihydrochloride in Treating Patients With Acute Myeloid Leukemia Completed Maxim Pharmaceuticals Phase 3 1998-07-01 RATIONALE: Interleukin-2 may stimulate a person's white blood cells to kill acute myeloid leukemia cells. Histamine dihydrochloride may prolong remission and reduce the risk of relapse in patients with acute myeloid leukemia in remission. PURPOSE: Randomized phase III trial to determine the effectiveness of interleukin-2 plus histamine dihydrochloride in treating patients who have acute myeloid leukemia that is in remission following previous therapy.
NCT00004316 ↗ Phase I/II Randomized, Placebo-Controlled Study of Capsaicin for Interstitial Cystitis and Vulvar Vestibulitis Completed University of Pittsburgh Phase 1/Phase 2 1995-06-01 OBJECTIVES: I. Estimate the optimal safe dose of intravesical capsaicin in patients with interstitial cystitis. II. Evaluate the efficacy of 0.025% topical capsaicin in relieving chronic burning pain in patients with vulvar vestibulitis. III. Evaluate the effect of capsaicin on type C nerve fibers in bladder mucosa and vulvar skin. IV. Evaluate the effect of C fiber depletion on urinary levels of histamine and prostaglandin.
NCT00004316 ↗ Phase I/II Randomized, Placebo-Controlled Study of Capsaicin for Interstitial Cystitis and Vulvar Vestibulitis Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Phase 1/Phase 2 1995-06-01 OBJECTIVES: I. Estimate the optimal safe dose of intravesical capsaicin in patients with interstitial cystitis. II. Evaluate the efficacy of 0.025% topical capsaicin in relieving chronic burning pain in patients with vulvar vestibulitis. III. Evaluate the effect of capsaicin on type C nerve fibers in bladder mucosa and vulvar skin. IV. Evaluate the effect of C fiber depletion on urinary levels of histamine and prostaglandin.
NCT00005038 ↗ Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Metastatic Kidney Cancer Unknown status The Christie NHS Foundation Trust Phase 2 1999-06-01 RATIONALE: Interleukin-2 may stimulate a person's white blood cells to kill kidney cancer cells. Histamine dihydrochloride may prolong survival and improve quality of life in patients with metastatic kidney cancer. PURPOSE: Randomized phase II trial to compare the effectiveness of interleukin-2 with or without histamine dihydrochloride in treating patients who have metastatic kidney cancer.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for histamine

Condition Name

Condition Name for histamine
Intervention Trials
Asthma 22
Allergic Rhinitis 17
Pruritus 7
Itch 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for histamine
Intervention Trials
Rhinitis 29
Rhinitis, Allergic 28
Asthma 18
Pruritus 11
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for histamine

Trials by Country

Trials by Country for histamine
Location Trials
United States 202
Canada 31
United Kingdom 22
Belgium 18
Germany 17
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for histamine
Location Trials
New York 19
Illinois 13
Texas 13
California 11
North Carolina 11
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for histamine

Clinical Trial Phase

Clinical Trial Phase for histamine
Clinical Trial Phase Trials
Phase 4 61
Phase 3 44
Phase 2/Phase 3 8
[disabled in preview] 50
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for histamine
Clinical Trial Phase Trials
Completed 162
Recruiting 39
Unknown status 25
[disabled in preview] 17
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for histamine

Sponsor Name

Sponsor Name for histamine
Sponsor Trials
GlaxoSmithKline 11
Aalborg University 10
Charite University, Berlin, Germany 5
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for histamine
Sponsor Trials
Other 285
Industry 106
NIH 23
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.